Acuitas is a biotechnology company that works with partners to develop new therapies to address unmet clinical needs based on our internationally recognized capabilities in delivery technology.
Acuitas is a private company based in Vancouver, British Columbia and was founded in February 2009. We are partnered with multiple pharmaceutical companies, biotechnology companies and academic institutes to advance nucleic acid therapeutics to the clinic and to the marketplace.
We work with partners and thought-leaders to advance nucleic acid therapeutics into clinical development and commercialization. Our vision is to provide delivery technology that fully enables nucleic acid medicines and thereby address unmet clinical needs.